Viewing Study NCT03393260


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2025-12-27 @ 5:54 AM
Study NCT ID: NCT03393260
Status: COMPLETED
Last Update Posted: 2020-01-07
First Post: 2017-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Epidemiological Characteristics and Prognosis Factors of Cancer Patients Admitted at French Emergency Departments
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Overview

Official Title: Epidemiological Characteristics and Prognosis Factors of Cancer Patients Admitted at French Emergency Departments
Status: COMPLETED
Status Verified Date: 2019-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EPICANCER
Brief Summary: Patients with cancer or hematological malignancy are susceptible to present acute complications linked to their disease or to their specific treatments (dyspnea, sepsis, coma, hemorrhagic syndrome). Emergency physicians are in first line when these complications arise and have to face with some complex situations in which informations about patient malignancy or prognosis may be lacking. Nowadays, there is very few epidemiological data published concerning how cancer patient use Emergency Departments (EDs) and cancer patient care delivery in the EDs.

Thus, an observational multicenter prospective cross-sectional study is conducted to study the prevalence of cancer patients admitted to French EDs, and to describe the different reasons for cancer patients to seek care in EDs with their prevalence and underscore those linked to cancer or treatment complication
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: